Sun Pharma shares fall 3 per cent after US FDA halts shipments to US from Mohali facility https://ift.tt/zxcwZF9

Sun Pharma's shares fell 3 per cent after the pharmaceutical company temporarily suspended production at its Mohali facility to comply with the US Food and Drug Administration (FDA)'s regulations. The company received a letter, titled “Consent Decree Correspondence/Non-Compliance Letter", instructing it to conduct certain corrective actions at the Mohali facility before resuming production. Sun Pharma stated that it is taking the necessary steps, but will temporarily pause the release of batches until the FDA-mandated measures have been implemented.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/yov17PR